WHEN TO CHOOSE A CHEMICAL PEEL OVER OTHER MODALITIES
NEW FRONTIERS IN COSMETIC MEDICINE AND MEDICAL DERMATOLOGY (NFCMMD) NOVEMBER 2019 KSENIYA GOLUBETS, MD, MHS SKIN AND LASER SURGERY SPECIALISTS OF NY & NJ
WHEN TO CHOOSE A CHEMICAL PEEL OVER OTHER MODALITIES NEW FRONTIERS - - PowerPoint PPT Presentation
WHEN TO CHOOSE A CHEMICAL PEEL OVER OTHER MODALITIES NEW FRONTIERS IN COSMETIC MEDICINE AND MEDICAL DERMATOLOGY (NFCMMD) NOVEMBER 2019 KSENIYA GOLUBETS, MD, MHS SKIN AND LASER SURGERY SPECIALISTS OF NY & NJ INTRO TO PEELS According
NEW FRONTIERS IN COSMETIC MEDICINE AND MEDICAL DERMATOLOGY (NFCMMD) NOVEMBER 2019 KSENIYA GOLUBETS, MD, MHS SKIN AND LASER SURGERY SPECIALISTS OF NY & NJ
Aesthetic Plastic Surgery … between 596,000 and 603,305 chemical peel procedures were performed in 2015, an increase of 25% compared with the previous year.1,2
Stats2015.pdf. Accessed February 2, 2017.
Accessed February 2, 2017.
PROS:
(PIH) in skin of color patients (no heat energy)
CONS:
texture/scabs after a laser
prior peel hx dictates depth of penetration and this side effect profile
fractionated) necrosis at the level lower reticular dermis
Subcutaneous Connective tissue Proteins Fibroblasts/fibrocytes Smaller vessels Nerve endings Lymph ducts
Skin texture:
smoker’s lines, buccal) YES!
sebaceous hyperplasia – PARTLY!
Skin discoloration
Connective tissue loss: start early to prevent face-lifts!!
PARTLY with DEEPER PEELS, plus volumizers and surgical lifts
controlled inflammation
penetration:
stratum spinosum and stratum basale
PA: Saunders; 2011; pp. 17–22.
Kontochristopoulos G, Platsidaki E. Chemical peels in active acne and acne scars. Clin Dermatol. 2017 Mar - Apr;35(2):179-182. doi: 10.1016/j.clindermatol.2016.10.011. Epub 2016 Oct 27. PubMed PMID: 28274356.
Classification of Chemical Peels by Depth of Injury Peel Type Depth (um) Level Injury Agent Superficial- very light <100 Exfoliating stratum corneum, +/- stratum granulosum Low potency AHA Salicylic acid 10-20% TCA Retinoic acid Superficial- light 100 Necrosis of entire epidermis to basal layer, stimulate regeneration of new epithelium 40-70% GA/AHA 22-30% TCA Jessners solution ViPeel Medium depth 200 Wound epidermis and papillary dermis, +/- upper reticular dermis; new collagen production 22-50% TCA (not recommended) Jessner + 35% TCA 70% glycolic+ 35% TCA Hetter VL (phenol) Deep >400 Necrosis of part or all mid reticular dermis; new collagen production >50% TCA Hetter Baker-Gordon peel
Modified from Table 1: Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan 31.
TCA (10–12% in alcohol), phenol (10–12%), salicylic acid (10–12%), tretinoin (0.1–0.4%), and 4% vitamin C
cardiopulmonary monitoring
Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan 31.
Classification of Chemical Peels by Depth of Injury Peel Type Depth (um) Level Injury Agent Superficial- very light <100 Exfoliating stratum corneum, +/- stratum granulosum Low potency AHA Salicylic acid 10-120% TCA Retinoic acid Superficial- light 100 Necrosis of entire epidermis to basal layer, stimulate regeneration of new epithelium 40-70% GA/AHA 22-30% TCA Jessner solution ViPeel Medium depth 200 Wound epidermis and papillary dermis, +/- upper reticular dermis; new collagen production 22-50% TCA (not recommended) Jessner + 35% TCA 70% glycolic+ 35% TCA Hetter VL (phenol) Deep >400 Necrosis of part or all mid reticular dermis; new collagen production >50% TCA Hetter Baker-Gordon peel
Modified from Table 1: Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan 31.
scarring and dyspigmentation, when TCA >50%
effective, but with better safety profile as compared to 50% TCA
peel
neutralized within 2 minutes to inhibit further penetration of the chemical agents
Obagi et al 1999
compared with 5-fluorouracil cream
reduction in AKs
Lawrence N. Arch Dermatol. 1995 Feb;131(2):176-81.
Classification of Chemical Peels by Depth of Injury Peel Type Depth (um) Level Injury Agent Superficial- very light <100 Exfoliating stratum corneum, +/- stratum granulosum Low potency AHA Salicylic acid 10-120% TCA Retinoic acid Superficial- light 100 Necrosis of entire epidermis to basal layer, stimulate regeneration of new epithelium 40-70% GA/AHA 22-30% TCA Jessner solution ViPeel Medium depth 200 Wound epidermis and papillary dermis, +/- upper reticular dermis; new collagen production 22-50% TCA (not recommended) Jessner + 35% TCA 70% glycolic+ 35% TCA Hetter VL (phenol) Deep >400 Necrosis of part or all mid reticular dermis; new collagen production >50% TCA Hetter Baker-Gordon peel
Modified from Table 1: Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan 31.
numbs skin
lab testing
septisol
croton oil – DENSE FROST
dermis
hypopigmentation can
appearance
toxicity and
Monheit 1995 Bensimon (Aesthetic Surg J 2008;28:33–45.)
72.
133–50.
, editors. Color Atlas of Chemical Peels. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2006; pp. 139–48. 7 R ll P K AM Ch i l l f d k ki F i l Pl S Cli N h A 2010 18 111 31
to reduce risk of greater peel penetration and potential post- inflammatory pigmentary changes
induction of dyschromias
72.
133–50.
, editors. Color Atlas of Chemical Peels. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2006; pp. 139–48. 7 R ll P K AM Ch i l l f d k ki F i l Pl S Cli N h A 2010 18 111 31
Jackson A. Chemical peels. Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan
Jackson A. Chemical peels. Facial Plast Surg. 2014 Feb;30(1):26-34. doi: 10.1055/s-0033-1364220. Epub 2014 Jan
Fabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080. Epub 2010 Oct 14. PubMed PMID: 20981308; PubMed Central PMCID: PMC2958495.
easy
cornified envelope surrounding cornified epithelioid cells
is used to treat dark skin
Fabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080. Epub 2010 Oct 14. PubMed PMID: 20981308; PubMed Central PMCID: PMC2958495.
symptoms
and back same day)
Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999 Jan;25(1):18-22. PubMed PMID: 9935087.
1. Spring et al. Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations. JAMA Dermatol. 2017 Aug 1;153(8):802-809. doi: 10.1001/jamadermatol.2017.2077. Review. PubMed PMID: 28658462. 2. Kar BR, Tripathy S, Panda M. Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne. J Cutan Aesthet Surg. 2013 Oct;6(4):204-8. doi: 10.4103/0974-2077.123403. PubMed PMID: 24470716; PubMed Central PMCID: PMC3884884. 3. Kontochristopoulos G, Platsidaki E. Chemical peels in active acne and acne scars. Clin Dermatol. 2017 Mar - Apr;35(2):179-182. doi: 10 1016/j li d t l 2016 10 011 E b 2016 O t 27 P bM d PMID 28274356
isotretinoin therapy
light peels safe to use
intervals showed improved MASI scores sooner than isotretinoin alone probably due to decreased sebo-production
see results sooner
Fabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080. Epub 2010 Oct 14. PubMed PMID: 20981308; PubMed Central PMCID: PMC2958495.
laser for acne scars
(50%) has similar results and much less adverse reactions
efficacy and tolerability with least number of sessions in the treatment of xanthelasma palpebrarum than 50% and 35% TCA peeling
Mourad B, Elgarhy LH, Ellakkawy HA, Elmahdy N. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum. J Cosmet Dermatol. 2015 Sep;14(3):209-15. doi: 10.1111/jocd.12148. Epub 2015 Aug 7. PubMed PMID: 26251333.
trichloroacetic acid 20% show better results than each individual modality in the treatment of atrophic acne scars? A randomized controlled trial. J Dermatolog Treat 2014;25: 137–41.
treatment of acne scars: a simultaneous split-face trial. Lasers Surg Med 2009;41:545–9.
weeks apart
effective in rolling scars
Kim HJ, Kim TG, Kwon YS, Park JM, Lee JH. Comparison of a 1,550 nm Erbium: glass fractional laser and a chemical reconstruction of skin scars (CROSS) method in the treatment of acne scars: a simultaneous split-face trial. Lasers Surg Med. 2009 Oct;41(8):545-9. doi: 10.1002/lsm.20796. PubMed PMID: 19639620.
resistant to the effect of chemical peels
maintenance regimens is essential in ensuring their efficacy while minimizing PIH
Pandya article on Melasma treatment: Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol. 2015 Aug;56(3):151-63. doi: 10.1111/ajd.12290. Epub 2015. Mar 9. Review. PubMed PMID: 25754098.
1. Fabbrocini G, De Padova MP , Tosti A. Superficial to medium-depth peels: a personal experience. In: Tung RC, Rubin MG, editors. Procedures in Cosmetic Dermatology Series: Chemical Peels (2nd ed). Philadelphia, PA: Saunders; 2011; pp. 123–32. 2. Iorizzo M, Tosti A, De Padova MP. Melasma. In: Tosti A, Grimes PE, De Padova MP , editors. Color Atlas of Chemical Peels. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2006; pp. 149–59. 3. Nadela RE. Chemical peeling for melasma. In: Handog EB, Enriquez- Macarayo MJ, editors. Melasma and Vitiligo in Brown Skin. New Delhi, India: Springer; 2017; pp. 133–5.
peels are best used as adjunctive therapy
lower concentrations, they are the safest and most efficacious peels to use in this group
1. Fabbrocini G, De Padova MP , Tosti A. Superficial to medium-depth peels: a personal experience. In: Tung RC, Rubin MG, editors. Procedures in Cosmetic Dermatology Series: Chemical Peels (2nd ed). Philadelphia, PA: Saunders; 2011; pp. 123–32. 2. Iorizzo M, Tosti A, De Padova MP. Melasma. In: Tosti A, Grimes PE, De Padova MP , editors. Color Atlas of Chemical Peels. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2006; pp. 149–59. 3. Nadela RE. Chemical peeling for melasma. In: Handog EB, Enriquez- Macarayo MJ, editors. Melasma and Vitiligo in Brown Skin. New Delhi, India: Springer; 2017; pp. 133–5.
Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999 Jan;25(1):18-22. PubMed PMID: 9935087.
term results for epidermal melasma, TCA peels should be used with caution in those with skin of color due to the risk of post- peel PIH and scarring
between six TCA peels and 10–35% GA peels
than TCA peels
less side effects
R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):447. doi: 10.4103/0378-6323.66602. PubMed PMID: 20657143.
monotherapy
risk of PIH
careful post-procedure instructions on sun protection and ongoing topical therapy
melasma, but rebound occurred
improvement had significantly decreased, to approximately 25%, with respect to both treatment modalities
Hong SP, Han SS, Choi SJ, Kim MS, Won CH, Lee MW, Choi JH, Moon KC, Kim YJ, Chang SE. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. J Cosmet Laser Ther. 2012 Apr;14(2):81-6. doi: 10.3109/14764172.2012.655287. Epub 2012 Feb 28. PubMed PMID: 22372386.
Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel
Vachiramon V, Sahawatwong S, Sirithanabadeekul P. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling. Dermatol Surg. 2015 Apr;41(4):457-65. doi: 10.1097/DSS.0000000000000304. PubMed PMID: 25760554.2. Kauvar AN. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers. Lasers Surg Med 2012;44:117–24.
Vachiramon V, Sahawatwong S, Sirithanabadeekul P. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling. Dermatol Surg. 2015 Apr;41(4):457-65. doi: 10.1097/DSS.0000000000000304. PubMed PMID: 25760554.2. Kauvar AN. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers. Lasers Surg Med 2012;44:117–24.
52